Follow-up Study of Autologous Cultured Adipose-derived Stem Cells for the Crohn's Fistula
NCT01314079 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 37
Last updated 2016-11-23
Summary
This is an open follow-up clinical trials to evaluate a sustained efficacy and safety of Adipoplus inj. for 10 months (12 months after final dose injection)after Phase II clinical trial.
Conditions
- Crohn's Disease
- Fistula
Sponsors & Collaborators
-
Anterogen Co., Ltd.
lead INDUSTRY
Principal Investigators
-
CS You, MD, PhD · Asan Medical Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-04-30
- Primary Completion
- 2012-08-31
- Completion
- 2012-08-31
Countries
- South Korea
Study Locations
More Related Trials
-
Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease
NCT01541579 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Adipose-Derived Stem Cells to Treat Complex Perianal Fistulas Patients With Crohn's Disease
NCT01378390 ·Status: TERMINATED ·Phase: PHASE3
-
Clinical Study to Evaluate Efficacy and Safety of ASC and Fibringlue or Fibringlue in Patients With Crohn's Fistula
NCT04612465 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Clinical Trial to Evaluate if the Laparoscopic Administration of Cells Derived From the Fatty Tissue Can Improve the Inflammatory Stenosis in Patient With Crohn's Disease
NCT05521672 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Treatment of Perianal Fistulas in Crohn's Disease With Autologous Microfragmented Adipose Tissue With the Lipogems System
NCT05766566 ·Status: UNKNOWN
-
Treatment of Fistulous Crohn's Disease by Implant of Autologous Mesenchymal Stem Cells Derived From Adipose Tissue
NCT01157650 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Assess the Safety and Efficacy of Expanded Allogenic Adipose-derived Stem Cells (eASCs) (Cx601), for Treatment of Complex Perianal Fistulas in Perianal Crohn's Disease.
NCT01372969 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD)
NCT03279081 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Perianal Disease Using Adipose-derived Stem Cells
NCT03913572 ·Status: UNKNOWN
-
Adipose Tissue Injection in Perianal Fistulas in Crohn´s Disease
NCT03904212 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Dose Escalation of Allogeneic Adipose Derived Stroma/Stem Cells for the Treatment of Crohn's Fistula
NCT06636032 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Follow-up Study to Evaluate the Safety of ALLO-ASC-CD in ALLO-ASC-CD-101 Clinical Trial
NCT03183661 ·Status: RECRUITING
-
A follow-on Safety Study in Subjects With Crohn's Disease Who Have Previously Been Withdrawn From the Double-blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] Due to an Exacerbation of Crohn's Disease
NCT00160706 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
NCT01277666 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the 12-month Efficacy of Stem Cell Injection in Crohn's Disease With Complex Ano-perineal Fistula
NCT05177003 ·Status: UNKNOWN
-
Pediatric MSC-AFP Sub-study for Crohn's Fistula
NCT03449069 ·Status: COMPLETED ·Phase: PHASE1
-
Mesenchymal Stem Cell Therapy for the Treatment of Severe or Refractory Inflammatory and/or Autoimmune Disorders
NCT01540292 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Micro-fragmented Adipose Tissue and Complex Crohns' Anal Fistulas
NCT03555773 ·Status: COMPLETED ·Phase: NA
-
Immune Ablation and Stem Cell Support for Crohn's Disease
NCT00179842 ·Status: WITHDRAWN ·Phase: PHASE2
-
A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]
NCT00160524 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Andecaliximab in Participants With Moderately to Severely Active Crohn's Disease
NCT02405442 ·Status: TERMINATED ·Phase: PHASE2
-
A Phase II Efficacy Study in Fistulizing Crohn's Disease Patients
NCT01355614 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety of ALLO-ASC-CD for Treatment of Crohn's Disease
NCT02580617 ·Status: UNKNOWN ·Phase: PHASE1
-
An Innovative Treatment for Fistula-in-ano in Crohn Disease : Local Micro Reinjection of Autologous Fat and SVF
NCT02520843 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Autologous Adipose-derived Stem Cells (ASCs) for the Treatment of Perianal Fistula in Crohn Disease: A Pilot Study
NCT02403232 ·Status: UNKNOWN ·Phase: PHASE2